Achilleas Gravanis
CEO ReNeuroCell Thearapeutics
Achilleas Gravanis, former Professor of Pharmacology, School of Medicine, University of Crete, and Researcher at the Institute of Molecular Biology & Biotechnology (IMBB), FORTH (Foundation for Research and Technology – Hellas). He is an Adjunct Professor of Pharmacology at the School of Pharmacy, Northeastern University, Boston.
He has served as a member of the European Commission’s Biomedical Research Programme Committee, a member of the Council of the Hellenic Authority for Higher Education Quality Assurance (HAHE), and President of the Sectoral Scientific Council of Life Sciences of the National Council for Research & Technology (NCRT).
He has also served as a member of the Scientific Council of the Hellenic Foundation for Research & Innovation (HFRI), responsible for Life Sciences, and as an Associate Principal Investigator at Emulate, a spin-off of the Wyss Institute/Harvard Medical School.
He is a co-founder of the biotechnology spin-off companies Bionature SA and ReNeuroCell Therapeutics, which are engaged in the development of new therapies for neurodegenerative diseases and brain injury.